未使用


着払いで発送します

Thomas-Kilmann Conflict Mode Instrument (TKI)

Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer (Review)

Frontiers | Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Take the TKI Conflict Test Online.

Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology

How We Treat Metastatic Renal Cell Carcinoma: Options Beyond First-Line Therapy

The mechanisms of acquired EGFR-TKI resistance. (a) The illustration of... | Download Scientific Diagram

PDF] The E3 ubiquitin ligase NEDD4 mediates EGFR-TKI acquired resistance in non-small cell lung cancer | Semantic Scholar

An Overview of the TKI Assessment Tool - Kilmann Diagnostics

TKI Group

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective | Signal Transduction and Targeted Therapy

HER2 Inhibitor | Clinical Research | InOncology

TKI CNC | CNC-machined performance parts and accessories

Frontiers | Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors

Tyrosine Kinase-Inhibitor (TKI)-sensitive and-resistant Tumors and the... | Download Scientific Diagram